DrugPatentWatch Database Preview
Drugs in Development Information for TRV130
Email this page to a colleague
» See Plans and PricingWhat is the drug development status for TRV130?
TRV130 is an investigational drug.
There have been 10 clinical trials for TRV130.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Acute Pain and [disabled in preview]. The leading clinical trial sponsors are Trevena Inc., Kestrel Biologic, and Lotus Clinical Research, LLC.
There are five US patents protecting this investigational drug and thirty-seven international patents.
Summary for TRV130
| US Patents | 5 |
| International Patents | 37 |
| US Patent Applications | 10 |
| WIPO Patent Applications | 6 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-06-01) |
| Vendors | 15 |
Recent Clinical Trials for TRV130
| Title | Sponsor | Phase |
|---|---|---|
| Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty | Trevena Inc. | Phase 3 |
| Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy | Trevena Inc. | Phase 3 |
| A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain | Trevena Inc. | Phase 3 |
Clinical Trial Summary for TRV130
Top disease conditions for TRV130
Top clinical trial sponsors for TRV130
US Patents for TRV130
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| TRV130 | Start Trial | Opioid receptor ligands and methods of using and making same | Trevena, Inc. (King of Prussia, PA) | Start Trial |
| TRV130 | Start Trial | Opioid receptor ligands and methods of using and making same | Trevena, Inc. (King of Prussia, PA) | Start Trial |
| TRV130 | Start Trial | Opioid receptor ligands and methods of using and making same | Trevena, Inc. (King of Prussia, PA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for TRV130
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| TRV130 | Australia | 2012230761 | 2031-03-23 | Start Trial |
| TRV130 | Australia | 2017200745 | 2031-03-23 | Start Trial |
| TRV130 | Brazil | 112013024136 | 2031-03-23 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
